because rigorously controlled human safety data specific to the TB-500 fragment does not exist, its longer-term risk profile, including possible immune reactions, remains unknown Evidence snapshot: Evidence for TB-500 itself is preclinical, drawn mainly from cell-culture and animal studies (a 1999 rat wound-healing study and later rodent cardiac- and tendon-injury models), with a 2026 scoping review describing the musculoskeletal literature on thymosin beta-4 and TB-500 as sparse and largely preclinical
Elamipretide: the first cardiolipin-directed mitochondrial therapeutic for Barth syndrome approved under accelerated approval
In this episode of the Huberman Lab, Huberman examines cortisol's role beyond its reputation as just a stress hormone, explaining how it helps deliver energy to tissues throughout the body and follows a natural 24-hour rhythm
Low Wang has found that patients do well if they pay close attention to when they start feeling full and stop eating at that point
Retatrutide is a relatively large molecule, and aggressive reconstitution can denature portions of it, reducing potency
